Agilent Technologies Inc (A) Receives Consensus Rating of “Buy” from Analysts

Shares of Agilent Technologies Inc (NYSE:A) have been assigned an average recommendation of “Buy” from the seventeen ratings firms that are covering the company, MarketBeat reports. Six research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $68.36.

Several brokerages have recently commented on A. Barclays increased their target price on shares of Agilent Technologies from $67.00 to $71.00 and gave the company an “overweight” rating in a report on Tuesday, November 21st. JPMorgan Chase & Co. increased their target price on shares of Agilent Technologies to $75.00 and gave the company an “overweight” rating in a report on Tuesday, November 21st. Deutsche Bank set a $75.00 target price on shares of Agilent Technologies and gave the company a “buy” rating in a report on Tuesday, November 21st. Cowen reiterated a “hold” rating and issued a $70.00 target price on shares of Agilent Technologies in a report on Wednesday, November 22nd. Finally, Robert W. Baird reiterated a “buy” rating and issued a $72.00 target price on shares of Agilent Technologies in a report on Friday, November 24th.

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 43,703 shares of the stock in a transaction dated Friday, January 5th. The shares were sold at an average price of $70.00, for a total transaction of $3,059,210.00. Following the completion of the transaction, the chief executive officer now owns 302,837 shares in the company, valued at $21,198,590. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Michael R. Mcmullen sold 22,481 shares of the stock in a transaction dated Monday, November 20th. The stock was sold at an average price of $70.00, for a total transaction of $1,573,670.00. Following the transaction, the chief executive officer now owns 327,882 shares of the company’s stock, valued at approximately $22,951,740. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 176,291 shares of company stock valued at $12,245,920.

Large investors have recently modified their holdings of the business. Dupont Capital Management Corp purchased a new stake in shares of Agilent Technologies in the third quarter worth about $101,000. Balentine LLC lifted its holdings in shares of Agilent Technologies by 2.9% in the second quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock worth $106,000 after buying an additional 50 shares in the last quarter. Sun Life Financial INC lifted its holdings in shares of Agilent Technologies by 26,144.4% in the second quarter. Sun Life Financial INC now owns 2,362 shares of the medical research company’s stock worth $140,000 after buying an additional 2,353 shares in the last quarter. Acrospire Investment Management LLC lifted its holdings in shares of Agilent Technologies by 92.3% in the second quarter. Acrospire Investment Management LLC now owns 2,500 shares of the medical research company’s stock worth $148,000 after buying an additional 1,200 shares in the last quarter. Finally, Fiduciary Trust Co. purchased a new stake in shares of Agilent Technologies in the second quarter worth about $186,000.

Shares of Agilent Technologies (NYSE:A) traded up $2.08 during mid-day trading on Tuesday, hitting $72.13. 1,543,379 shares of the stock traded hands, compared to its average volume of 1,644,900. The stock has a market capitalization of $23,190.00, a P/E ratio of 34.51, a P/E/G ratio of 2.11 and a beta of 1.28. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30. Agilent Technologies has a 52 week low of $47.05 and a 52 week high of $70.93.

Agilent Technologies (NYSE:A) last announced its earnings results on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.05. The company had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.17 billion. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. The firm’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.59 earnings per share. equities research analysts predict that Agilent Technologies will post 2.58 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 24th. Investors of record on Tuesday, January 2nd will be given a dividend of $0.149 per share. The ex-dividend date is Friday, December 29th. This represents a $0.60 annualized dividend and a yield of 0.83%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. Agilent Technologies’s dividend payout ratio is presently 28.71%.

ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/01/agilent-technologies-inc-a-receives-consensus-rating-of-buy-from-analysts.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply